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Research
The aryl hydrocarbon receptor (AHR) is a 
cytosolic ligand-activated transcription factor 
in the basic region–helix-loop-helix–PER-
ARNT-SIM (bHLH-PAS) family of pro-
teins (Crews and Fan 1999). Its activation by 
prototypical ligands such as benzo[a]pyrene 
(BaP), 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), coplanar polychlorinated biphe-
nyls, and many other ligands causes its trans-
location to the nucleus, where it dimerizes 
with a second bHLH-PAS protein, aryl 
hydrocarbon receptor nuclear translocator 
(ARNT), to form a heterodimeric transcrip-
tion factor. AHR/ARNT complexes bind to 
canonical DNA consensus sequences and ini-
tiate transcription of genes coding for many 
phase I and phase II detoxification enzymes 
(Hankinson 1995). In addition, the AHR 
complex regulates the expression of genes 
whose products control a broad spectrum of 
cellular functions, such as cell division and 
cell fate (Marlowe and Puga 2005). Because 
so many of its ligands are known or suspected 
carcinogens, a disproportionate amount of 
AHR research has focused on the analysis of 
the toxicologic or adaptive end points that it 
mediates. Over the years, however, the AHR 
has also been found to activate signal trans-
duction pathways that run parallel to these 
detoxification pathways, often in the absence 
of stimulation by an exogenous ligand 
(Marlowe and Puga 2005).
Mice with a homozygous ablation of the 
Ahr gene are viable but suffer numerous age-
related pathologies involving multiple organ 
systems (Fernandez-Salguero et al. 1995), 
suggesting that the AHR has endogenous 
functions that do not require activation by 
xenobiotic ligands and that play an impor-
tant role in maintenance of cellular homeo-
stasis (Bock and Kohle 2006). Teratogenic 
end points of dioxin, such as the induction 
of cleft palate in mouse embryos (Abbott 
et al. 1994), are at the crossroads of develop-
mental and toxic signals, providing impor-
tant clues to the nature of such homeostatic 
AHR functions. Receptor activation by envi-
ronmental chemicals is likely to have the 
dual effect of disrupting homeostasis while 
simultaneously triggering the induction of 
detoxification pathways. Testing this pos-
sibility is one of the main objectives of the 
present study.
The ancestral function of the AHR 
appears to be the regulation of specific aspects 
of embryonic development, having acquired 
the ability to bind xenobiotic compounds 
only during vertebrate evolution (Hahn 
2002). The invertebrate AHR protein also 
functions as a transcription factor and binds 
to the same dimerization partner and cis-
acting response elements as the vertebrate 
protein, but it does not respond to any of the 
environmental ligands recognized by the ver-
tebrate receptor. Instead, it regulates diverse 
developmental processes that are indepen-
dent of toxicant or of exogenous ligand expo-
sure, such as neuronal differentiation during 
development in Caenorhabditis elegans (Qin 
and Powell-Coffman 2004) and normal mor-
phogenesis of legs, antennae, and bristles in 
Drosophila melanogaster (Adachi-Yamada et al. 
2005). In keeping with this role in inverte-
brates, the mammalian AHR also possesses 
a developmental role in craniofacial, renal, 
and cardiovascular morphogenesis (Birnbaum 
et al. 1989; Fernandez-Salguero et al. 1997; 
Lahvis et al. 2005), raising the key question 
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Ba c k g r o u n d: The vertebrate aryl hydrocarbon receptor (AHR) is a ligand-activated transcription 
factor that regulates cellular responses to environmental polycyclic and halogenated compounds. 
The naive receptor is believed to reside in an inactive cytosolic complex that translocates to the 
nucleus and induces transcription of xenobiotic detoxification genes after activation by ligand.
oB j e c t i v e s: We conducted an integrative genomewide analysis of AHR gene targets in mouse 
hepatoma cells and determined whether AHR regulatory functions may take place in the absence of 
an exogenous ligand.
Me t h o d s : The network of AHR-binding targets in the mouse genome was mapped through a 
multipronged approach involving chromatin immunoprecipitation/chip and global gene expression 
signatures. The findings were integrated into a prior functional knowledge base from Gene Ontology, 
interaction networks, Kyoto Encyclopedia of Genes and Genomes pathways, sequence motif analysis, 
and literature molecular concepts.
re s u l t s: We found the naive receptor in unstimulated cells bound to an extensive array of gene clus-
ters with functions in regulation of gene expression, differentiation, and pattern specification, con-
necting multiple morphogenetic and developmental programs. Activation by the ligand displaced the 
receptor from some of these targets toward sites in the promoters of xenobiotic metabolism genes.
co n c l u s i o n s: The vertebrate AHR appears to possess unsuspected regulatory functions that may 
be potential targets of environmental injury.
key w o r d s : Ah receptor, ChIP-on-chip, gene–environment interactions, gene regulation, gene tar-
get networks. Environ Health Perspect 117:1139–1146 (2009).  doi:10.1289/ehp.0800485 available 
via http://dx.doi.org/ [Online 24 March 2009]Sartor et al.
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of whether its ancestral function has been 
retained during vertebrate evolution.
Knowledge of the range of genes directly 
regulated by the AHR would facilitate integra-
tion at a systems biology level of the complex 
physiologic mechanisms that this receptor 
regulates both endogenously and in response 
to toxic ligands. In the present study, we com-
bined multiple technologies and knowledge 
bases to conduct an integrative genomewide 
analysis of AHR gene targets in mouse hepa-
toma cells. Assuming no a priori knowledge of 
the results of the present study, we conclude 
that the AHR is likely a key regulator of genes 
with a function during embryonic develop-
ment, suggesting that gene–environment 
interactions during fetal life may be potential 
triggers of developmental abnormalities.
Materials and Methods
A detailed description of all   materials 
and methods used can be found in the 
Supplemental Material (available online at 
http://www.  ehponline.org/members/0800485/
suppl.pdf).
Cell culture and chemical treatments. 
Mouse Hepa-1c1c7 (Hepa-1) cells, and its 
mutant derivative c35 expressing a DNA-
binding defective AHR (Sun et al. 1997), 
were grown in α-minimal essential medium 
supplemented with 5% (vol/vol) fetal bovine 
serum, 26 mM NaHCO3, and 1% (vol/vol) 
antibiotic-antimycotic mixture at 37°C in a 
humidified 5% CO2 atmosphere. When the 
cells reached 70–80% confluence, we treated 
them with the standard ligand concentrations 
that give maximal induction responses for 
xenobiotic detoxification genes, 5 µM BaP or 
5 nM TCDD, and 0.1% dimethyl sulfoxide 
(DMSO) vehicle as control. Cells were then 
harvested 1.5 hr and 8 hr posttreatment for 
chromatin immunoprecipitation (ChIP) and 
RNA extraction, respectively.
Transcriptome analysis: experimental 
design and procedure. We performed com-
parative transcriptome profiling of DMSO-, 
BaP-, and TCDD-treated Hepa-1c1c7 and 
c35 cells using the Affymetrix GeneChip 
Mouse Genome 430 2.0 Array (Santa Clara, 
CA). Eight hours posttreatment, three indi-
vidual RNA extractions from three biological 
replicates of 5 × 106 cells were prepared, and 
total RNA was extracted using NucleoSpin 
RNA  II  columns  (Macherey-Nagel; 
Bethlehem, PA). We validated RNA extracts 
for quality and integrity using the Agilent 
2100 Bioanalyzer (Santa Clara, CA). 
ChIP and target preparation. We per-
formed ChIP as previously described 
(Schnekenburger et al. 2007), using ChIP-
verified anti-AHR antibody (Biomol, 
Plymouth Meeting, PA) and control nonim-
mune rabbit IgG (Upstate, Billerica, MA). 
An aliquot of immunoprecipitated purified 
DNA was checked for immunoprecipita-
tion efficiency by real-time polymerase chain 
reaction (PCR) using primers specific for the 
mouse Cyp1a1 promoter domains known to 
be bound by AHR. We observed a significant 
enrichment (16- to 32-fold) for the specific 
AHR target relative to the control antibody. 
For target preparation, immunoprecipitated 
DNA was PCR-amplified and labeled accord-
ing to the standard protocol supplied by 
Affymetrix (http://www.affymetrix.com/prod-
ucts/arrays/specific/mouse_promoter.affx).
Quantitative real-time PCR analysis. 
We performed quantitative polymerase chain 
reactions (QPCRs) in triplicate for approxi-
mately 6% of the 750 top-ranked genes 
scored by whole-genome hybridization and 
established the statistical significance of the 
differential expression by the empirical Bayes 
t-test as implemented in the Bioconductor 
limma package (Smyth 2004; http://bioinf.
wehi.edu.au/limma/). p-Values were adjusted 
for multiple comparisons using Benjamini-
Hochberg false discovery rate (FDR) proce-
dures (Benjamini and Hochberg 1995).
Expression microarray hybridization 
and analysis. Hybridization to Affymetrix 
GeneChip Mouse Genome Arrays was per-
formed with biotinylated amplified total 
RNA, followed by staining and washing using 
the Affymetrix GeneChip Hybridization 
Wash and Stain Kit. Analysis of differen-
tially expressed genes used R statistical soft-
ware (R Project 2009) and the Bioconductor 
limma package (Smyth 2004). We assessed 
chip quality using the   affyQCReport pack-
age of Bioconductor. Estimated fold changes 
for each comparison were calculated using 
analysis of variance (ANOVA) and signifi-
cance was assessed using an intensity-based 
Bayesian moderated t-statistic (IBMT) (Sartor 
et al. 2006). We considered genes satisfy-
ing an FDR < 0.05 level of significance and 
showing a minimum fold change > 50% to be 
  differentially expressed.
Binding site identification. Raw data 
were quantile normalized and all array-
pairwise Pearson correlation coefficients 
were determined to be > 0.95. We used the 
Bioconductor limma package (Smyth 2004) 
to perform ANOVA on normalized probes 
and calculated significance levels for probes 
using IBMT (Sartor et al. 2006). We removed 
from subsequent analyses probes with inten-
sities in the lowest 20% [see Supplemental 
Material (http://www.ehponline.org/
members/0800485/suppl.pdf)] for the identi-
fication of AHR-bound gene promoters.
Functional analysis and clustering. Gene 
Ontology (GO) (2009) terms and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) 
(2009) pathways were tested for enrichment 
of binding and/or differential expression using 
Fisher’s exact test. For ChIP/chip conditions, 
we used the list of 750 top-ranked genes; for 
the 5-nucleo  tide motif, we identified 562 genes 
with ≥ 12 sites within 2 kb of the transcription 
start site (TSS); and for the longer motif, we 
identified 693 genes with at least two sites in 
the promoter and at least one of those within 
2 kb of the start site. For expression results, we 
also used the 750 top-ranked up-/down-regu-
lated genes in wild-type versus c35 cells. These 
gene lists were then clustered based on their 
level of enrichment in the biological processes 
in GO [see Supplemental Material (http://
www.ehponline.org/members/0800485/
suppl.pdf) for further details of the methods. 
Clustering can be viewed interactively at http://
eh3.uc.edu/supplements/ahrchip by following 
the link Hierarchical clustering of enriched 
GO terms at the bottom of the page].
Results
Strategy for AHR target gene network map-
ping. Evidence accumulated over the years 
shows that the network of genes regu  lated by 
the vertebrate AHR may extend well beyond 
those genes induced as a consequence of 
exposure to xenobiotic ligands (Barouki et al. 
2007). To develop a comprehensive analysis of 
genomic sites bound by the AHR and of possi-
ble target changes resulting from perturbation 
of gene–environment cues, we used mouse 
hepatoma Hepa-1c1c7 cells, which have been 
extensively studied in AHR signaling work, 
exposed to either of two AHR ligands, BaP 
or TCDD, or in an exogenous ligand-naive 
environment exposed to the control solvent 
DMSO. To provide direct verification of the 
unique and specific role of the AHR protein 
in the results, we compared binding data from 
these cells with data from the Hepa-1c1c7 
mutant derivative c35 cell line, which has a 
missense mutation in the Ahr gene. This muta-
tion blocks the ability of the AHR protein 
to bind DNA, although the mutated AHR 
protein retains its ability to bind ligand and 
translocate to the nucleus (Sun et al. 1997). 
Under these conditions, we identified the 
AHR network of target binding sites with a 
multipronged approach that included the col-
lection of experimental signatures and their 
integration into a prior functional knowledge 
base. ChIP with anti-AHR or nonimmune 
IgG anti  bodies was followed by whole-genome 
amplification and microarray hybridization 
(ChIP/chip) to the Affymetrix GeneChip 
Mouse Promoter 1.0R Array. ChIP/chip 
information, binding sequence motif analysis, 
and global gene expression profiling, using the 
Affymetrix GeneChip Mouse Genome 430 
2.0 Array, provided one arm of the approach, 
which we combined with an extensive prior 
functional knowledge derived from GO, inter-
action networks, KEGG pathways, and lit-
erature molecular concepts. Figure 1 shows 
a schematic representation of the integrative Aryl hydrocarbon receptor regulatory network
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approach, focused on developing a compre-
hensive physiologic understanding of this 
gene’s regulatory network.
AHR ChIP/chip profiling. ChIP/chip 
experiments showed distinct AHR binding 
signals in naive and ligand-exposed wild-
type Hepa-1c1c7 cells but no signal in the 
mutant c35 cells, indicating that the signal 
was entirely AHR dependent. The probe den-
sity in the array chip was biased in the neigh-
borhood of the TSS (± 1 kb), the same region 
where the highest binding signal intensity for 
the top 15% of probes was also strongest [see 
Supplemental Material, Figure 1A (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. After normalizing for probe 
density distribution, we found AHR-bound 
regions encompassing multiple consecutive 
probes to be preferentially located in the 
neighborhood of the TSS for naive as well as 
ligand-exposed wild-type cells, although we 
also identified many such regions outside this 
2-kb symmetric region around the TSS [see 
Supplemental Material, Figure 1B (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. Surprisingly, the strongest signal 
within 1 kb of the TSS was not in ligand-
exposed cells, but in naive DMSO-treated 
cells. In contrast, c35 cells, whether naive or 
TCDD treated, showed no evidence of pref-
erential binding along gene promoters, indic-
ative of the inability of the mutant AHR in 
these cells to bind to DNA [see Supplemental 
Material, Figure 1B (http://www.ehponline.
org/docs/2009/0800485/suppl.pdf)].
To identify the most likely AHR tar-
gets under each experimental condition, we 
selected genes based on the statistical signifi-
cance of their overall z-score of binding. This 
resulted in approximately 750 genes signifi-
cantly bound by the AHR in naive, DMSO-
treated wild-type cells, using a local FDR 
< 0.10 criterion (Efron 2004; Taylor et al. 
2005). All three comparisons of anti-AHR ver-
sus IgG immunoprecipitations from DMSO-, 
TCDD-, and BaP-treated cells resulted in 
approximately 750 ± 30 unique genes satisfy-
ing the criterion of z-score > 4.0 (p < 1.6 × 
10–5). Supplemental Material, Table 1 (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf) lists the 750 top-ranked genes for 
each experimental comparison. Three unex-
pected findings clearly stand out from these 
initial analysis results. First is the large number 
of gene promoter regions that show signifi-
cant AHR binding in naive cells, in agree-
ment with the high signal observed around 
the TSS and the high proportion of sites to 
satisfy the specified binding criteria in naive 
cells [see Supplemental Material (http://www.
ehponline.org/docs/2009/0800485/suppl.pdf) 
for the derivation of parameter pc under “Gene 
scoring algorithm”]. This finding is sugges-
tive of a physiologic role for the receptor in 
the absence of an exogenous ligand. Second 
is the large proportion of top-ranked genes 
in naive cells that have functions involved in 
transcriptional regulation, including a large 
number of homeobox genes. Third is the large 
fraction of top-ranked AHR-binding genes in 
naive cells that are not found in ligand-treated 
cells and the comparative gain of other genes 
in cells exposed to either ligand. Supplemental 
Material, Figure 2 (http://www.ehponline.org/
docs/2009/0800485/suppl.pdf) shows differen-
tial binding profiles for a select group of genes 
chosen from among the 750 top-ranked genes.
To independently validate the ChIP/chip 
results, a second set of ChIP experiments was 
performed on chromatin extracts from naive- 
and BaP- and TCDD-treated cells by two 
researchers not involved in the first experimen-
tal series. We processed these samples by real-
time QPCR for the detection of 46 promoter 
regions chosen from 41 unique genes among 
the 750 top-ranked genes [see Supplemental 
Material, Table 1 (http://www.ehponline.org/
docs/2009/0800485/suppl.pdf)], plus Cyp1a1 
added as a positive control. These genes were 
not selected at random, but were chosen on the 
Figure 1. Schematic representation of the integrative approach. To develop a comprehensive view of the AHR 
target network, we analyzed gene expression and DNA binding data under a variety of gene–environment 
combinations, including wild-type cells and cells with a DNA-binding–deficient mutant AHR, in naive cells 
and in cells exposed to two different ligands, BaP and TCDD. Experimental signatures under these conditions 
were determined by ChIP/chip assays, binding sequence motif analysis, and global gene expression profil-
ing. Data were combined with an extensive prior functional knowledge base derived from GO, interaction 
networks, KEGG pathways, and literature molecular concepts. Ultimately, this integrated approach will lead 
to a physiologic understanding of indigenous AHR functions and of the molecular basis of gene–environment 
interactions controlled by the AHR that lead to the derailment of normal biological processes.
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Figure 2. Independent verification of ChIP/chip results by real-time QPCR of a select group of genes. 
Primer pairs were selected to amplify short segments (< 200 bp) of the promoter regions of the genes 
shown here. The y-axis shows the log2 ratio of the QPCR Ct values of amplified DNA from ChIP with anti-
AHR antibodies relative to nonimmune control IgG.
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basis of a z-score > 4, and their membership in a 
significantly enriched GO term or KEGG path-
way. They belong to widely differing functional 
categories, including regulation of transcription, 
organ morphogenesis, brain development, and 
others not expected from prior knowledge to 
be regulated by the AHR. Also included were 
xenobiotic metabolism genes, known to be 
regulated by the AHR, and several tumor sup-
pressor and other genes involved in the onset 
or progression of proliferative diseases, such 
as Pten, Foxo3a, Cyr61, Prox1, and Pik3r1. 
[see Supplemental Material, Table 1 (http://
www.ehponline.org/members/0800485/suppl.
pdf) for the Entrez identification and accession 
number of all genes mentioned in this article]. 
Pten was one of the genes showing higher AHR 
binding in naive cells than in BaP- or TCDD-
treated cells, a finding that we verified by the 
validation experiments (p = 0.0025 for BaP and 
p = 0.0155 for TCDD). All but four of the 46 
promoter regions were verified (FDR < 0.10) 
for at least one of either the naive (39 of 46) or 
BaP- (42 of 46) or TCDD- (40 or 46) treated 
cells (Figure 2).
Functional analysis of AHR bound genes 
in naive and in ligand-activated cells. We 
performed functional enrichment analysis 
with the 750 top-ranked ChIP/chip genes 
of all comparisons using KEGG pathways, 
GO, and Ingenuity pathway analysis (http://
www.ingenuity.com) The top enriched 
biological processes for naive cells included 
anatomical structure morphogenesis; organ 
morpho  genesis; blood vessel morphogenesis; 
vasculature development; positive regulation 
of nucleobase; nucleoside, nucleotide, and 
nucleic acid metabolic processes; angiogenesis; 
positive regulation of cellular metabolic pro-
cesses; blood vessel development; and embry-
onic morphogenesis (p < 0.001; FDR < 0.15). 
At this level of significance, KEGG did not 
reveal any enriched pathways in naive cells. 
The top-scoring Ingenuity pathway net-
work for naive cells (score = 50) included 
the transcription factors cJUN and NR2F1 
[Supplemental Material, Figure 3 (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)], both of which have previously 
been shown to interact with the AHR (Hoffer 
et al. 1996; Klinge et al. 2000) and the WNT 
pathway, which is also known to interact with 
the AHR (Mathew et al. 2008). In agreement 
with our findings using GO categories, this 
Ingenuity pathway network was significantly 
enriched with the function development of 
organs (p = 1.08 × 10–8) and development 
of brain (p = 1.48 × 10–6). As the negative 
control, we tested the top 750 genes from the 
ChIP of naive c35 cells for enriched functional 
categories in GO and found no significantly 
enriched categories (all q-values = 1).
The functional enrichment analysis 
of the genes determined to be more highly 
bound by AHR when cells were treated 
with TCDD or BaP than when they were in 
the naive state identified the KEGG path-
way “metabolism of xenobiotics by cyto-
chrome P450” as enriched when cells were 
exposed to either ligand (BaP, p = 0.00056; 
TCDD, p = 0.039). Specific genes included 
Aldh3a1 (both ligands), Cyp1b1 (TCDD), 
Gstk1 (BaP), Gstt1 (TCDD), Ephx1 (BaP), 
Cyp3a41a (BaP), Cyp3a16 (both ligands), 
Cyp2c55 (TCDD), Gsto2 (BaP), Ugt1a10 
(BaP), Ugt1a6a (BaP), Ugt1a2 (BaP), Gstm1 
(BaP), Cyp2f2 (TCDD), and Mgst1 (TCDD). 
Previously unbeknownst to us, the promoter 
of the best known of the positive controls, 
Cyp1a1, was incorrectly tiled on the mouse 
Affymetrix promoter array and therefore was 
absent from the ChIP-chip analyses.
Integration of sequence signatures into the 
AHR target network. To assess whether the 
genes detected by AHR ChIP/chip conformed 
to the presence of previously established AHR 
binding sites, we analyzed two AHR bind-
ing motifs, the canonical 5-nucleotide motif 
5´-GCGTG-3´ and the longer 18-bp motif 
5´-CCYCNRRSTNGCGTGASA-3´ derived 
from nine binding sites in the mouse and rat 
P450 genes, as defined by the TRANSFAC 
position weight matrix (PWM) V$AHR_01 
(Matys et al. 2003). Both motifs showed the 
same distribution of relative positions with 
respect to the TSS of known genes, but of 
the two motifs, the shorter [see Supplemental 
Material, Figure 4A (http://www.ehponline.
org/docs/2009/0800485/suppl.pdf)] gave 
a higher peak signal-to-noise ratio than did 
the longer motif (4.5- vs. 3-fold ratio) [see 
Supplemental Material, Figure 4B (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. Functional enrichment analy-
ses comparing the categories of genes sig-
nificantly enriched in the canonical binding 
motif with categories identified on the basis 
of ChIP/chip results from naive cells (see 
“Materials and Methods”) revealed 14 bio-
logical processes that were enriched in both 
analyses at the p < 0.01 level. Based on our 
random simulations accounting for the corre-
lations in the GO hierarchical structure, such 
a high number of processes in common with 
p < 0.01 was highly unlikely to have occurred 
by chance (p << 0.001; maximum of three 
overlapping from 1,000 random simulations). 
These overlapping categories delineated two 
process lineages, one relating to regulation of 
transcription and the other including several 
developmental processes, such as brain devel-
opment, blood vessel morphogenesis (with its 
parent, organ morphogenesis), and tube mor-
phogenesis (Figure 3). The inset in Figure 3 
illustrates the degree of overlap in func-
tional enrichment results between sequence 
motif and several ChIP/chip comparisons. 
We ranked biological processes in terms of 
Figure 3. Indigenous AHR functions in naive cells. Functional categories identified based on ChIP/chip 
results from naive cells were integrated with those from sequence data, resulting in 14 overlapping terms 
with p < 0.01, significantly more than expected by chance (maximum of three overlapping from 1,000 ran-
dom simulations; p << 0.001). These overlapping categories delineated the two process lineages shown, 
one relating to positive regulation of biological processes and leading to the regulation of transcription, 
and the other including many developmental processes. The three processes framed with dashed lines 
were significant at p < 0.05 and are included here for continuity. The inset shows the number of GO terms 
in common between various enrichment tests and enrichments based on the five-nucleotide canonical 
motif. Ranked lists of GO terms were calculated for ChIP/chip data of naive wild-type, and BaP- and TCDD-
treated cells, naive c35 cells, and random simulations. The inset plots the number of overlapping terms 
between each set and enrichments based on the five-nucleotide canonical motif for increasing length of 
ranked lists, as well as the expected values based on Fisher’s exact test.
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significance for all functional enrichment tests 
and calculated the numbers of processes in 
common for increasing length of ranked lists 
for results based on sequence motif versus 
ChIP/chip results from naive, BaP-treated, 
TCDD-treated, and negative control c35 
cells. To determine the number of processes 
in common that could be expected to be 
enriched by chance, we calculated the mean 
number of overlapping terms from 1,000 
random simulations between sequence motif 
and naive wild-type cells (dashed line) as well 
as the expected overlap by chance based on 
Fisher’s exact test (solid black line), again for 
increasing length of ranked lists. Thus, the 
inset to Figure 3 shows the degree of over-
lap in enriched biological processes for the 
entire range of the top 5–100 ranked pro-
cesses, rather than for any single cutoff alone. 
Using the naive c35 cells as a negative control, 
we found no signi  ficant overlap between top-
ranked biological processes in these cells and 
those identified on the basis of sequence motif 
knowledge. These results support and extend 
the findings based on ChIP/chip data alone.
Distribution of AHR binding sites in genes 
predicted by ChIP/chip. To characterize the 
distribution of predicted AHR binding sites 
in the promoters of genes belonging to the 
enriched processes found in the functional 
analyses, we created histograms of relative 
locations of predicted AHR motif locations 
for genes identified by ChIP/chip in enriched 
categories, and for genes in the same enriched 
categories that were not identified by ChIP/
chip. Specific enriched categories used were 
brain development, blood vessel morphogen-
esis, tube morphogenesis, positive regulation 
of transcription, anatomical structure forma-
tion, and, to serve as a negative control, mem-
brane. For each gene list, we also created a 
histogram of the overall background distribu-
tion of predicted AHR motifs around known 
TSS. Enrichment of AHR motifs was evident 
in those genes that scored by ChIP/chip [see 
Supplemental Material, Figure 4A (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf) compared with the genes in 
the same categories that did not score [see 
Supplemental Material, Figure 4B (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. When we based the analysis on 
top-ranked ChIP/chip genes assigned to any 
enriched biological process on the basis of 
ChIP/chip data alone (i.e., not using any 
sequence-based information), the pattern of 
genes identified by ChIP/chip was again dis-
tinguishable from the pattern of genes not 
identified by ChIP/chip, which was closer 
to the pattern observed for all genes [see 
Supplemental Material, Figure 4C (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. Although a quantitative estimate 
of power is not feasible for the ChIP/chip 
assay, these graphs provide strong evidence 
that our experiments identified a high per-
centage of the AHR target genes involved in 
these biological processes.
Rarely is a gene regulated by a single tran-
scription factor binding in isolation. More 
often, promoters of developmentally regu-
lated and other genes have binding sites for 
multiple transcription factors that bind either 
simultaneously in a complex, or sequentially, 
as developmental or metabolic demands so 
require. To identify transcription factors that 
potentially interact with the AHR or work 
to coregulate genes with AHR, we examined 
the overlap between genes predicted to have a 
specific transcription factor binding motif in 
their promoters and genes whose promoters 
were bound by AHR, as determined from our 
ChIP/chip results. For each of the 267 mouse 
transcription factors with at least one PWM 
in the TRANSFAC version 12.1 database, we 
scored genes based on to how likely they were 
to have such a motif within 2 kb at either side 
of their TSS. For each transcription factor, 
we then calculated whether the top-scoring 
ChIP/chip genes had significantly more bind-
ing motifs than the rest of the genes using 
the nonparametric Mann–Whitney ranking 
test and Fisher’s exact test for the top 10% 
highest-scoring genes (see “Materials and 
Methods”). The two tests were in close agree-
ment (Pearson’s correlation between p-values, 
r > 0.82 for all three experimental conditions). 
The results with c35 mutant cells served as a 
negative control, and indeed, they showed no 
significant interacting transcription factors at 
the FDR < 0.10 level. We identified numerous 
transcription factors having an odds ratio of 
enrichment > 1.5 and FDR < 0.01 for both 
statistical tests. These included general tran-
scription factors involved in developmental 
processes (e.g., USF and E2A), proteins coded 
for by homeobox genes (e.g., Foxn1, Pax5, and 
Nkx5.1), and several other transcription fac-
tors [estrogen receptor (ER), HIF, Myc/Max, 
CREB, p53, and HNF4] previously known or 
suspected to interact with the AHR (Barouki 
et al. 2007). Combinatorial regulatory interac-
tions between ER and AHR are the subject 
of much current investigation (Pocar et al. 
2005). Although we detected similar interact-
ing transcription factors with the genes in all 
three experimental settings, the genes bound 
by AHR in the naive state provided a stron-
ger enrichment of interacting transcription 
factors in general and of the AHR in particu-
lar. Overall, 70, 9, and 20 transcription fac-
tors motifs were found for DMSO-, BaP-, 
and TCDD-treated cells, respectively, at the 
FDR < 0.01 level in both the Fisher’s exact 
test and Mann–Whitney test. Figure 4 shows 
significance values [as –log(p)] of the Mann–
Whitney test for a select set of transcription 
factor TRANSFAC entries for ChIP results 
from naive and BaP- and TCDD-treated cells.
Generation of an alternative positional 
weight matrix (PWM) for the AHR. We 
tested the individual AHR PWMs defined by 
TRANSFAC separately, to determine whether 
the promoters of the top-ranked ChIP/chip 
genes had greater enrichment with one than 
with the other. Of the two individual AHR 
PWMs defined by TRANSFAC, V$AHR_
Q5 (M00778) scored very high (Fisher’s 
Figure 4. Transcription factor overlap with the AHR network. For each of the 267 mouse transcription fac-
tors with at least one PWM in the TRANSFAC version 12.1 database and two novel entries we developed 
for AHR, we scored genes as to how likely they were to have a binding motif within 2 kb at either side 
of their TSS. For each transcription factor, we used the nonparametric Mann–Whitney ranking test and 
Fisher’s exact test (using a top 10th percentile cutoff for motifs) to calculate whether the top-scoring ChIP/
chip genes had significantly more binding motifs than the rest of the genes. The graph shows the results of 
the Mann–Whitney ranking test for the top 30 transcription factors mapping to the same promoter regions 
as the AHR.
25
20
15
10
5
0
–
L
o
g
(
p
)
A
p
2
E
2
F
1
H
I
F
1
c
.
M
y
c
.
M
a
x
T
T
F
.
1
.
N
k
x
2
.
1
.
E
2
A
Z
i
c
1
Z
i
c
2
p
5
3
Z
i
c
3
E
g
r
1
C
P
2
B
a
c
h
2
S
M
A
D
4
M
y
o
g
e
n
i
n
E
R
C
R
E
B
V
D
R
N
F
k
B
F
o
x
n
1
H
N
F
4
.
C
O
U
P
M
y
o
D
A
H
R
E
1
2
I
k
a
r
o
s
C
A
C
D
M
O
V
O
.
B
U
S
F
2
.
B
Z
F
5
S
p
1
L
R
F
W
T
1
A
H
R
.
D
M
E
.
4
k
b
DMSO
BaP
TCDDSartor et al.
1144  v o l u m e  117 | n u m b e r 7 | July 2009  •  Environmental Health Perspectives
exact p = 7.5 × 10–8, 0.0021, and 0.00019 
for DMSO, BaP, and TCDD, respectively), 
whereas the other, V$AHR_01 (M00139), 
was not significant (p = 0.060, 0.13, and 
0.16). This result suggests that PWM 
V$AHR_Q5 (M00778), which is virtually 
identical to the canonical five-nucleotide motif 
5´-GCGTG-3´, may provide the more accu-
rate description of the murine AHR binding 
motif, given the present data.
Bound promoter sequences of the QPCR-
verified genes were used to identify an alterna-
tive PWM for the AHR. Fragments of 100 
bp, each including the short five-nucleotide 
motif (5´-GCGTG-3´), were input into 
Discriminating Matrix Enumerator (DME) 
software (Smith et al. 2005). We obtained 
most discriminating six-, seven-, eight-, and 
nine-nucleotide PWMs using two different 
random promoter regions as background, 
one 2 kb on either side of TSS (AHR.
DME.4kb), and the other 7 kb upstream to 
3 kb downstream of TSS (AHR.DME.10kb) 
[see Supplemental Material, Table 2 (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. By removing the genes whose 
promoter sequences were used in creating 
these new PWMs, we were able to perform 
an unbiased comparison of the new PWMs 
and the previously defined TRANSFAC 
PWMs for AHR. Using the rest of the ChIP/
chip identified genes for DMSO-, BaP-, and 
TCDD-treated cells and the same methods as 
described above, we tested for enrichment of 
these motifs. The results in Fisher’s exact test 
showed that the previously defined AHR in 
TRANSFAC was slightly more highly signifi-
cant, whereas Mann–Whitney U-tests resulted 
in our novel motifs being more significant 
[see Supplemental Material, Table 2 (http://
www.ehponline.org/docs/2009/0800485/
suppl.pdf)]. We provide here our novel AHR 
PWMs as an alternative definition of equal or 
perhaps greater quality than that previously 
defined. Figure 4 includes two additional 
entries for the AHR constructed based on our 
experimental results using the DME software 
(Smith et al. 2005). Using the same approach, 
we tested the individual AHR PWMs defined 
by TRANSFAC separately and identified 
novel PWMs using ChIP regions verified by 
real-time QPCR.
Integration of expression profiling into the 
AHR target network. The AHR transcrip-
tional induction profile has been extensively 
studied, whether activated by TCDD, by 
BaP, or in the absence of exogenous ligands 
(Frericks et al. 2007). In addition to using 
prior knowledge to integrate expression pro-
files into the AHR gene target network, we 
performed a new set of expression profile 
analyses of the wild-type Hepa-1c1c7 and 
the mutant c35 cell lines and compared the 
responses in naive cells with responses in cells 
exposed to TCDD or BaP for 8 hr. Results of 
our new expression array studies were in close 
agreement with current knowledge. For exam-
ple, present among the 74 genes significant 
at FDR < 0.05 level were Cyp1a1, Aldh3a1, 
Nqo1, Adh7, Cyp1b1, Hspa4l, Vegfc, Xdh, 
Tiparp, and Tnfaip2. Functional enrichment 
analysis identified metabolism of xenobiot-
ics by cytochrome P450 as the sole enriched 
category or pathway (FDR < 0.1) involving 
the genes Adh7, Cyp1a1, Cyp1b1, Aldh3a1, 
and Cyp2s1 in BaP- and TCDD-treated cells; 
additionally, Adh1 was induced by TCDD 
only and Mgst2 by BaP only. The difference 
in response to ligand between wild-type and 
c35 cells was stark. No single, individual gene 
was significantly differentially expressed at the 
FDR < 0.1 level for the mutant c35 line under 
TCDD or BaP treatment.
The differential expression profile between 
naive wild-type and mutant cells involved 
several thousand genes. Functional analysis of 
genes more highly expressed in wild-type cells 
identified many of the same processes already 
found on the basis of overlapping ChIP/
chip and sequence data. Specifically, at the 
p < 0.01 level, overlapping processes included 
positive regulation of cellular processes, posi-
tive regulation of transcription, blood vessel 
development, vasculature development, and 
organ morphogenesis. At the p < 0.05 cutoff 
level, we additionally identified terms related 
to cell cycle arrest and regulation of growth as 
being enriched in both ChIP/chip and expres-
sion data, in good agreement with known dif-
ferences previously observed between Ahr+/+ 
and Ahr–/– cells (Chang et al. 2007). Genes 
in some other groups such as brain develop-
ment that we found to be enriched by ChIP/
chip and sequence data were not significantly 
more highly expressed in wild-type than in 
c35 cells. This may be the consequence of 
these genes not being expressed in hepatoma 
cells, but yet having a poised AHR that may 
still occupy the promoter at appropriate motif 
sites without causing changes in transcription.
Clustering of enriched processes for an 
overall integrative view. Integration of ChIP/
chip information, sequence motif data, and 
expression analysis with prior functional 
knowledge converged on the overall clustering 
heat map of GO biological processes identi-
fied as enriched in one or more experimental 
conditions (Figure 5). The clustering of func-
tional enrichment significance scores visually 
integrates three independent data sources—
ChIP/chip, sequence motif, and expression 
profiles. We divided the clustering into eight 
distinct clusters of categories, labeled A–H, 
each contributing significant information to 
the overall interpretation of results. Note that, 
as would be expected, virtually all clusters are 
identified based on sequence motif informa-
tion, and that no cluster is enriched in the 
ChIP/chip data of naive c35 mutant cells. 
Cluster A comprises processes identified by 
sequence, by ChIP/chip in naive wild-type 
cells, and as up-regulated in wild-type versus 
c35 mutant, but not by ChIP/chip in BaP- or 
TCDD-treated wild-type cells. These mainly 
represent processes involved in regulation of 
growth and transcription. Cluster C also rep-
resents processes identified by sequence and 
ChIP/chip in naive wild-type cells and by 
up-regulation in expression of wild-type ver-
sus c35 mutant cells, and to a certain extent 
in BaP- and TCDD-treated wild-type cells. 
These include positive regulation of transcrip-
tion, vascular development, organ morpho-
genesis, and metabolic processes. Cluster B 
contains processes enriched by genes with 
Figure 5. Functional heat map of GO biological pro-
cesses that are AHR targets. Abbreviations: 5-NT, 
five nucleotide; WT, wild type. The clustering of GO 
biological process enrichment scores visually inte-
grates three independent data sources—ChIP/chip, 
sequence motif, and expression profiles. The clus-
tering is divided into eight distinct clusters, labeled 
A–H, each contributing significant information to the 
overall interpretation of results. Each column repre-
sents enrichment results of one individual com-
parison from one of the three data sources. Eighty 
categories were first identified containing > 10 and 
< 1,000 genes that were enriched within at least 
one of the gene lists (FDR < 0.2). For each gene list, 
an “enrichment profile” was constructed consisting 
of –log(Fisher’s test p-value of enrichment) for each 
of these 80 GO terms. Gene lists and GO terms were 
then clustered based on such “enrichment pro-
files” using the simple Euclidian-distance–based 
average-linkage hierarchical clustering. 
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increased expression in wild-type versus c35 
cells, including processes related to mRNA 
processing and transport, suggestive of the 
likelihood that these processes are indepen-
dent of AHR binding to DNA. Many of these 
genes do not have canonical AHR binding 
sites, which raises the possibility that AHR 
binds to them indirectly, through protein–
protein interactions with other transcription 
factors, as is the case of AHR–retinoblastoma 
(RB) and AHR–E2F1 interactions (Ge and 
Elferink 1998; Marlowe et al. 2008). Clusters 
D and G comprise processes related to cell 
death, proliferation, and regulation of apop-
tosis and are enriched based on sequence and 
expression data, but not ChIP/chip, of naive 
cells. These might be involved in regulatory 
mechanisms that include cyclical, short-lived 
recruitment of the AHR to gene promoters, 
such as has previously been observed for other 
AHR ligands (Hestermann and Brown 2003). 
Cluster E represents gene groups identified by 
sequence and ChIP/chip data and comprises 
several processes related to nervous system 
development, embryonic development, eye 
development, tube morphogenesis, angiogen-
esis, and patterning of blood vessels. Most 
of these were not well enriched in expres-
sion data, and thus they may comprise sets of 
genes on whose promoters AHR is poised but 
not currently active or that may be silenced 
by epigenetic mechanisms, such as hyper-
methylation. Cluster F consists of processes 
enriched mainly based on sequence and, to 
a certain extent, ChIP/chip of naive and/or 
BaP- and TCDD-treated cells, and includes 
relatives of mitotic cell cycle and neuron 
development. Those processes enriched in 
this cluster may be representative of AHR-
dependent, xenobiotic-induced gene regula-
tion. We identified the processes in cluster H 
based on sequence alone and included pro-
cesses related to specific embryonic and other 
developmental processes, such as chordate 
embryonic development, regulation of synap-
tic plasticity, auditory receptor cell differen-
tiation, and embryonic development ending 
in birth or egg hatching. The genes involved 
in these processes may not be susceptible of 
activation in hepatoma cells.
Discussion
In this study, we have identified a genome-
wide network of AHR-regulated target genes 
and their biological functions by integrat-
ing information from our analyses of ChIP, 
binding motifs, and global gene expression. 
These analyses have been conducted with a 
mouse hepatoma cell line commonly used 
in AHR signaling work and have been con-
trolled at every step by similar studies done on 
a derivative cell line bearing a receptor with 
a missense mutation that inhibits its bind-
ing to DNA, hence providing an important 
biological verification of the results. The 
network so identified constitutes a critical 
new resource for the study of AHR-regulated 
gene expression that will help generate a bet-
ter understanding of the physiologic role of 
the AHR in the intact organism and of the 
health effects of human population exposure 
to AHR ligands.
Some of our findings are indeed surpris-
ing, and it could be argued that they are 
spurious, because of contaminating cross-re-
activities in our anti-AHR and control IgG 
antibodies. This and other trivial explanations 
for our results are ruled out by the control 
experiments with c35 cells, which, should 
the purity of our antibodies be questionable, 
would have given similar results as the experi-
mental Hepa-1 cells. Although the current 
paradigm of AHR function involves activa-
tion by xenobiotic ligands as an obligatory 
step in AHR translocation and function, our 
data show that the receptor not only occupies 
a significant number of its target promoters 
in naive, unstimulated cells, but also actively 
participates in the regulation of many of the 
genes that it occupies under these condi-
tions. However surprising in their extent and 
magnitude, these results are not totally unex-
pected and to some extent could have been 
predicted, given the abundant examples in 
the literature of a regulatory role for the AHR 
in the absence of xenobiotic ligand activation 
both in cultured cells and in vivo. By mecha-
nisms independent of xenobiotic metabolism, 
AHR knockout mice suffer from an impaired 
cardiovascular phenotype, which includes the 
failure of fetal vascular structures in the liver 
and eye to undergo apoptosis (Lahvis et al. 
2000), and from a fibrotic hepatic phenotype, 
complicated with premature senescence char-
acteristics (Fernandez-Salguero et al. 1995). 
In addition, a growing body of experimental 
evidence strongly suggests a role for the AHR 
in cell proliferation, differentiation, and liver 
and immune system homeostasis, as well as 
in tumor development (Barouki et al. 2007). 
Moreover, failure of specific GABAergic 
neurons to develop is the hallmark of abla-
tion of the C. elegans Ahr ortholog (Qin and 
Powell-Coffman 2004), as is the abnormal 
morphogenesis of legs, antennae, and bristles 
in Drosophila (Adachi-Yamada et al. 2005). 
In this regard, cleft palate and hydroneph-
rosis, two of the teratogenic end points of 
dioxin exposure during mouse embryonic 
development (Abbott et al. 1994), might be 
the result of the derailment of endogenous 
AHR morphogenetic functions. This might 
also be the case for the cardiac toxicity of 
TCDD (Aragon et al. 2008) and the recently 
found crosstalk between AHR and WNT 
in tissue regeneration in zebrafish (Mathew 
et al. 2008). Although the orthodox view is 
that AHR activation is followed by changes 
in its compartmentalization within the cell, 
little is known about the role that endogenous 
AHR ligands, such as tryptophan photoprod-
ucts (Wei et al. 1999), lipoxin A4 (Schaldach 
et al. 1999), cAMP (Oesch-Bartlomowicz 
et al. 2005), or indole derivatives (Song et al. 
2002), might have in the nuclear transloca-
tion of AHR in the absence of xenobiotic 
ligands. Growing evidence indicates that the 
AHR may be in a continued state of nucleo-
cytoplasmic shuttling (Pollenz 2002; Song 
and Pollenz 2002), which may provide the 
necessary temporal localization to bind to 
chromatin and exert its regulatory functions. 
It would be reasonable to conclude that the 
AHR possesses a set of endogenous functions 
that are independent of its activation as a 
transcription factor by xenobiotic ligands and 
that these functions may perform a regulatory 
role during development.
Exposure to either of the two xenobiotic 
ligands in this study, BaP or TCDD, causes a 
pronounced shift in the gene clusters targeted 
by the AHR, such that many of those identi-
fied in naive cells were no longer recognized 
by the receptor when activated by either BaP 
or TCDD, whereas the metabolism of xeno-
biotics pathway in KEGG emerged as a tar-
geted pathway in treated cells. It was apparent 
that each ligand activated the AHR to target 
gene clusters in common with those in naive 
cells as well as new clusters, some common to 
receptors activated by both ligands, and some 
ligand specific. For example, most clusters 
in group C (Figure 5), involved in vascular 
development, positive regulation of transcrip-
tion, and metabolic processes, were targeted in 
naive cells and to a lesser extent in cells treated 
with either ligand, whereas clusters of genes 
involved in regulation of growth and tran-
scription from RNA polymerase II promoters 
(group A) and in nervous system develop-
ment, embryonic development, eye develop-
ment, tube morphogenesis, angio  genesis, and 
patterning of blood vessels (group E) were 
AHR targets only in naive cells. These find-
ings may have serious implications on the 
etiology of diseases caused by AHR ligands, 
because any observed changes in gene regula-
tion resulting from exposure might be due 
not to new regulatory units being recognized 
by the activated receptor, but to loss of regu-
lation of preexisting ones in the unexposed 
organism. Given the known role of AHR 
ligands and other environmental agents in 
cardiovascular disease, it seems reasonable to 
conclude that the etiology of environmental 
cardiovascular disease may be connected with 
the AHR clusters involved in cardiovascular 
function, angiogenesis, or patterning of blood 
vessels (groups C and E). Similarly, the etiol-
ogy of proliferative diseases may depend on 
gene clusters regulating cell death or prolifera-
tion and mitosis (groups D, F, and G). A case Sartor et al.
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in point in this context may be the tumor 
suppressor gene Pten, which we verified by 
QPCR as being more highly bound by AHR 
in naive cells than in BaP- or TCDD-treated 
cells. Ablation of the Bmpr1a gene in the hair 
follicle bulge has recently been shown to sig-
nal PTEN inhibition, induction of follicle 
stem cell proliferation and inhibition of dif-
ferentiation through β-catenin stabilization 
and LEF1 activation (Kobielak et al. 2007). 
PTEN inhibition by TCDD exposure might 
initiate a similar sequence of events leading to 
chloracne, the hyperproliferative disease of the 
hair follicle that is a consequence of TCDD-
induced disease in humans.
An extended group of gene clusters (groups 
E and H) is involved in biological processes 
governing embryonic development and pattern-
ing of developmental structures. Several genes 
in these clusters are homeobox genes, which in 
turn control the concerted cascade of expres-
sion of other genes, potentially amplifying the 
regulatory capabilities of the AHR. Exposure to 
AHR ligands during embryonic life may derail 
the concerted expression of developmental 
genes and, in addition, alter the normal patterns 
of epigenetic modifications of these genes, an 
effect that might persist throughout the lifetime 
of the organism and possibly be a determinant 
of disease susceptibility in the adult.
The results from the present study provide 
a unique resource that should advance our 
ability to establish needed gene–environment 
connections between environmental disease 
and disturbances of gene regulation patterns 
at the level of the whole genome. We should 
emphasize that it is evident that some of the 
networks uncovered here will be limited to 
hepatoma cells in culture and include genes 
bound by a poised receptor but not necessar-
ily transcriptionally activated. In an organism, 
each cell lineage or tissue will have its own 
specific target network, including unique as 
well as overlapping domains. Given the large 
enrichment of developmental clusters in the 
AHR target network, a higher order under-
standing of the connections among disease 
state, environment, and AHR target genes 
will require extending these studies to the 
diverse tissues of the developing organism 
and defining a target network map at the level 
of the whole organism, a task that will be 
feasible after the knowledge base developed 
from the work presented here. Because AHR 
activation by its ligands generates chromatin 
modifications and changes in histone code 
(Schnekenburger et al. 2007), it is likely that 
any environmental injury that might occur in 
the developing embryo as a consequence of 
exposure to AHR ligands will cause persistent 
changes of gene expression for the life of the 
organism. The molecular basis of adult envi-
ronmental disease might be rooted in expo-
sures occurring during fetal life; if this were 
the case, understanding adult environmental 
diseases may require the synergistic interac-
tion of toxicology and developmental biology.
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